SCHEMBL15823889

SCHEMBL15823889

O=S(=O)(O)c1cc(N=C=S)ccc1C=Cc1ccc(N=C=S)cc1S(=O)(=O)O.[NaH].[NaH]

nearest known ligand 0.97

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY6 Q15077 2/20 0.97
RAD1 O60671 1/20 0.97
RAD51 Q06609 6/20 0.70
HSD17B10 Q99714 3/20 0.70
KDM4E B2RXH2 2/20 0.70
USP2 O75604 2/20 0.70
ALDH1A1 P00352 2/20 0.70
LTA P01374 2/20 0.70
CYP3A4 P08684 2/20 0.70
MAPT P10636 2/20 0.70
HPGD P15428 2/20 0.70
P2RX3 P56373 2/20 0.70
TDP1 Q9NUW8 2/20 0.70
SENP2 Q9HC62 5/20 0.52
SENP1 Q9P0U3 5/20 0.52
SENP3 Q9H4L4 4/20 0.52
SUMO2 P61956 3/20 0.52
SUMO1 P63165 3/20 0.52
SENP7 Q9BQF6 3/20 0.52
ENPP2 Q13822 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27168234 1.00 P2RY6 (0.97) P2RY6RAD1RAD51HSD17B10KDM4E
SCHEMBL439381 1.00 P2RY6 (0.97) P2RY6RAD1RAD51HSD17B10KDM4E
SCHEMBL38213 0.98 P2RY6 (1.00) P2RY6RAD1RAD51HSD17B10KDM4E
SCHEMBL38212 0.98 P2RY6 (1.00) P2RY6RAD1RAD51HSD17B10KDM4E
SCHEMBL29350628 0.98 P2RY6 (1.00) P2RY6RAD1RAD51HSD17B10KDM4E
SCHEMBL29351286 0.98 P2RY6 (1.00) P2RY6RAD1RAD51HSD17B10KDM4E
SCHEMBL439383 0.97 P2RY6 (0.97) P2RY6RAD1RAD51HSD17B10KDM4E
SCHEMBL2286120 0.97 P2RY6 (0.97) P2RY6RAD1RAD51HSD17B10KDM4E
SCHEMBL31481692 0.97 P2RY6 (0.97) P2RY6RAD1RAD51HSD17B10KDM4E
SCHEMBL11231850 0.91 RAD1 (0.86) P2RY6RAD1RAD51HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2934110-B1 USE OF CONNEXIN CHANNEL INHIBITORS TO PROTECT GRAFTS UNIV GENT (BE) 2018-08-01 EP claimed
US-9485983-B2 Use of connexin channel inhibitors to protect grafts UNIVERSITEIT GENT (BE) 2016-11-08 US claimed
US-20150313208-A1 USE OF CONNEXIN CHANNEL INHIBITORS TO PROTECT GRAFTS UNIVERSITEIT GENT (BE) 2015-11-05 US claimed
EP-2934110-A1 USE OF CONNEXIN CHANNEL INHIBITORS TO PROTECT GRAFTS Universiteit Gent (BE) 2015-10-28 EP claimed
WO-2014095468-A1 USE OF CONNEXIN CHANNEL INHIBITORS TO PROTECT GRAFTS UNIVERSITEIT GENT (BE) 2014-06-26 WO claimed
US-20240233860-A1 METHOD FOR MODELING CYCLIC 3D EPITOPES TO BE USED IN THE DEVELOPMENT OF VACCINES SYNTHETIC VACCINES LTD (GB) 2024-07-11 US disclosed
EP-3735262-A1 GLUCOSE OXIDASE COMPOSITIONS AS A NEONATE ANTICONVULSANT Penn State Research Foundation (US) 2020-11-11 EP disclosed
WO-2019136168-A1 GLUCOSE OXIDASE COMPOSITIONS AS A NEONATE ANTICONVULSANT PENN STATE RESEARCH FOUNDATION (US) 2019-07-11 WO disclosed
EP-2934110-B1 USE OF CONNEXIN CHANNEL INHIBITORS TO PROTECT GRAFTS UNIV GENT (BE) 2018-08-01 EP disclosed
US-9485983-B2 Use of connexin channel inhibitors to protect grafts UNIVERSITEIT GENT (BE) 2016-11-08 US disclosed
US-20150313208-A1 USE OF CONNEXIN CHANNEL INHIBITORS TO PROTECT GRAFTS UNIVERSITEIT GENT (BE) 2015-11-05 US disclosed
EP-2934110-A1 USE OF CONNEXIN CHANNEL INHIBITORS TO PROTECT GRAFTS Universiteit Gent (BE) 2015-10-28 EP disclosed
WO-2014095468-A1 USE OF CONNEXIN CHANNEL INHIBITORS TO PROTECT GRAFTS UNIVERSITEIT GENT (BE) 2014-06-26 WO disclosed